MD (Pediatrix Medical Group, Inc.) Stock Analysis - Insider Trades
Pediatrix Medical Group, Inc. (MD) is a publicly traded Healthcare sector company. As of May 21, 2026, MD trades at $22.47 with a market cap of $1.86B and a P/E ratio of 10.71. MD moved -2.06% today. Year to date, MD is +2.60%; over the trailing twelve months it is +48.22%. Its 52-week range spans $11.04 to $24.99. Analyst consensus is buy with an average price target of $23.33. Rallies surfaces MD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who is trading MD stock inside the company?
Recent MD insider activity includes Weis Shirley A sold 36.03K, ORDAN MARK S sold 23.00K, Rucker Michael A. sold 10.48K, Linynsky Laura A sold 10.00K, and ORDAN MARK S sold 27.60K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
MD Key Metrics
Key financial metrics for MD
Metric
Value
Price
$22.47
Market Cap
$1.86B
P/E Ratio
10.71
EPS
$2.09
Dividend Yield
0.00%
52-Week High
$24.99
52-Week Low
$11.04
Volume
0
Avg Volume
0
Revenue (TTM)
$1.93B
Net Income
$174.22M
Gross Margin
0.00%
Recent MD Insider Trades
Weis Shirley A sold 36.03K (~$855.66K) on May 13, 2026.
ORDAN MARK S sold 23.00K (~$515.43K) on Dec 15, 2025.
Rucker Michael A. sold 10.48K (~$240.99K) on Nov 17, 2025.
Linynsky Laura A sold 10.00K (~$216.50K) on Nov 6, 2025.
ORDAN MARK S sold 27.60K (~$423.66K) on Nov 13, 2024.
Recent MD insider activity includes Weis Shirley A sold 36.03K, ORDAN MARK S sold 23.00K, Rucker Michael A. sold 10.48K, Linynsky Laura A sold 10.00K, and ORDAN MARK S sold 27.60K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for MD?
Yes. Rallies tracks MD insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is MD research on Rallies investment advice?
No. Rallies provides research, data, and educational context for MD. It does not provide personalized investment advice.